News Focus
News Focus
Post# of 257252
Next 10
Followers 5
Posts 973
Boards Moderated 0
Alias Born 03/03/2011

Re: DewDiligence post# 120614

Thursday, 05/26/2011 6:03:47 PM

Thursday, May 26, 2011 6:03:47 PM

Post# of 257252
Another positive for AMR101

So AMR101/EPADEL is the ONLY DRUG to have proven CV outcomes over statin monotherapy

AMR101 has potential to capture NIACIN market. Niaspan alone sells for $1 billion

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now